Keyphrases
AAV9
16%
Adenovirus
16%
Angiotensin II (Ang II)
33%
Autophagosome
16%
Autophagosome Accumulation
33%
Cardiac Hypertrophy
16%
Cardiac Phenotype
16%
Cardiac Protection
16%
Cardiomyopathy
100%
Danon Disease
16%
Dilated Cardiomyopathy
16%
Drug Effects
16%
Drug Therapy
100%
Drug Use
16%
Exon 6
50%
Fibrosis
33%
Gene Therapy
100%
Heart Failure
33%
Heart Failure Medication
100%
Highly Effective
16%
Human Patients
16%
Hypertrophy
16%
IP Injection
16%
LAMP2
100%
LAMP2 mutation
16%
Left Ventricular Hypertrophy
16%
Lysosomal Function
16%
Metoprolol
16%
Molecular Markers
16%
Neonate
16%
Novel Therapies
16%
Oxidative Stress
33%
Preclinical Animal Models
16%
RAAS Inhibitors
16%
Ramipril
33%
Spironolactone
33%
Systolic Dysfunction
16%
Systolic Function
16%
Troponin Release
16%
Ventricular Dilatation
16%
Ventricular Dysfunction
16%
Wall Thickness
16%
X-linked Disorder
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adeno Associated Virus
33%
Angiotensin II
66%
Cardiomyopathy
100%
Congestive Cardiomyopathy
33%
Danon Disease
33%
Experimental Mouse
33%
Fibrosis
66%
Heart Failure
100%
Heart Left Ventricle Hypertrophy
33%
Heart Ventricle Hypertrophy
33%
Metoprolol
33%
Molecular Marker
33%
Mouse
66%
Mouse Model
33%
Ramipril
66%
Spironolactone
66%
Systolic Dysfunction
33%
Troponin
33%
X Chromosome Linked Disorder
33%